Beta-adrenergic agonist

WikiDoc Resources for Beta-adrenergic agonist
Articles
Most recent articles on Beta-adrenergic agonist Most cited articles on Beta-adrenergic agonist Review articles on Beta-adrenergic agonist Articles on Beta-adrenergic agonist in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Beta-adrenergic agonist Images of Beta-adrenergic agonist Photos of Beta-adrenergic agonist Podcasts & MP3s on Beta-adrenergic agonist Videos on Beta-adrenergic agonist
Evidence Based Medicine
Cochrane Collaboration on Beta-adrenergic agonist Bandolier on Beta-adrenergic agonist TRIP on Beta-adrenergic agonist
Clinical Trials
Ongoing Trials on Beta-adrenergic agonist at Clinical Trials.gov Trial results on Beta-adrenergic agonist Clinical Trials on Beta-adrenergic agonist at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Beta-adrenergic agonist NICE Guidance on Beta-adrenergic agonist NHS PRODIGY Guidance FDA on Beta-adrenergic agonist CDC on Beta-adrenergic agonist
Books
Books on Beta-adrenergic agonist
News
Beta-adrenergic agonist in the news Be alerted to news on Beta-adrenergic agonist News trends on Beta-adrenergic agonist
Commentary
Blogs on Beta-adrenergic agonist
Definitions
Definitions of Beta-adrenergic agonist
Patient Resources / Community
Patient resources on Beta-adrenergic agonist Discussion groups on Beta-adrenergic agonist Patient Handouts on Beta-adrenergic agonist Directions to Hospitals Treating Beta-adrenergic agonist Risk calculators and risk factors for Beta-adrenergic agonist
Healthcare Provider Resources
Symptoms of Beta-adrenergic agonist Causes & Risk Factors for Beta-adrenergic agonist Diagnostic studies for Beta-adrenergic agonist Treatment of Beta-adrenergic agonist
Continuing Medical Education (CME)
CME Programs on Beta-adrenergic agonist
International
Beta-adrenergic agonist en Espanol Beta-adrenergic agonist en Francais
Business
Beta-adrenergic agonist in the Marketplace Patents on Beta-adrenergic agonist
Experimental / Informatics
List of terms related to Beta-adrenergic agonist

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Assistant Editor-in-Chief: Somal Khan, M.D.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Beta-adrenergic agonists are adrenergic agonists which act upon the beta receptors.

β₁ agonists

Main article: Beta-1 adrenergic receptor § agonists

β₁ agonists: stimulates adenylyl cyclase activity; opening of calcium channel. (cardiac stimulants; used to treat cardiogenic shock, acute heart failure, bradyarrhythmias). Selected examples are:

• Dobutamine
• Isoproterenol (β₁ and β₂)

β₂ agonists

Main article: Beta-2 adrenergic receptor § agonists

β₂ agonists: stimulates adenylyl cyclase activity; closing of calcium channel (smooth muscle relaxants; used to treat asthma and COPD). Selected examples are:

• salbutamol (albuterol in USA)
• Fenoterol
• Formoterol
• Isoproterenol (β₁ and β₂)
• Metaproterenol
• Salmeterol
• Terbutaline
• Clenbuterol

Undetermined/unsorted

The following agents are also listed as agonists by MeSH.

• arbutamine
• befunolol
• bromoacetylalprenololmenthane
• broxaterol
• cimaterol
• cirazoline
• denopamine
• dopexamine
• epinephrine
• etilefrine
• hexoprenaline
• higenamine
• isoetharine
• isoxsuprine
• mabuterol
• methoxyphenamine
• nylidrin
• oxyfedrine
• pirbuterol
• prenalterol
• procaterol
• ractopamine
• reproterol
• rimiterol
• ritodrine
• tretoquinol
• tulobuterol
• xamoterol
• zinterol

References

Template:Receptor agonists and antagonists